- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Accelerate Diagnostics Inc (0H8E)
Assess today's live Accelerate Diagnostics Inc (AXDXQ) share price, performance and insights using our live OTC Markets: AXDXQ stock exchange data.
Analyse the historical data and Accelerate Diagnostics Inc share price performance charts on this page. Our technical summary section provides analysis on Accelerate Diagnostics share price buy/sell indicators using real-time data (or discuss the Accelerate Diagnostics (AXDXQ) stock price today with other investors in the Accelerate Diagnostics OTC share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current OTC AXDXQ share price (ISIN: US00430H2013) to enhance your trading decisions with our free investment tools and resources.
What Is the Accelerate Diagnostics Inc Share Price Today?
The Accelerate Diagnostics share price today is 0.02.
What Is the Stock Symbol for Accelerate Diagnostics Inc
The stock symbol (or 'ticker') for Accelerate Diagnostics Inc is "AXDXQ."
What Stock Exchange Does Accelerate Diagnostics Inc Trade On?
Accelerate Diagnostics Inc is listed and trades on the OTC Markets stock exchange.
Is Accelerate Diagnostics Inc a Good Stock to Buy?
Determining whether Accelerate Diagnostics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Accelerate Diagnostics Inc share price performance charts on this page. Our technical summary section provides analysis on Accelerate Diagnostics share price buy/sell indicators using real-time data (or discuss the Accelerate Diagnostics (AXDXQ) stock price today with other investors in the Accelerate Diagnostics OTC share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current OTC AXDXQ share price (ISIN: US00430H2013) to enhance your trading decisions with our free investment tools and resources.
What Is the Accelerate Diagnostics Inc Share Price Today?
The Accelerate Diagnostics share price today is 0.02.
What Is the Stock Symbol for Accelerate Diagnostics Inc
The stock symbol (or 'ticker') for Accelerate Diagnostics Inc is "AXDXQ."
What Stock Exchange Does Accelerate Diagnostics Inc Trade On?
Accelerate Diagnostics Inc is listed and trades on the OTC Markets stock exchange.
Is Accelerate Diagnostics Inc a Good Stock to Buy?
Determining whether Accelerate Diagnostics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
0.02
0.00(0.00%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.02
0.03
52 wk Range
0.01
1.98
0H8E Scorecard
Full Analysis
Operates with a significant debt burden
0H8E is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.020.03
52 wk Range
0.011.98
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
0H8E Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
- Accelerate Diagnostics grants CEO retention bonus
- Investing.com
- Accelerate Diagnostics files for Chapter 11 protection
- Investing.com
Pro
Accelerate Diagnostics Inc Company Profile
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States and internationally. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing (AST) of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides Accelerate PhenoTest BC Kit, a test kit for the system, which is indicated as an aid, in conjunction with other clinical and laboratory findings, in the diagnosis of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. In addition, the company offers Accelerate Arc system, an instrument and associated one-time-use test kit that automates the clean-up and concentration of microbial cells from positive blood culture samples. Further, it develops Accelerate WAVE system, which performs AST directly from positive blood culture bottles and bacterial isolate colonies to report minimum inhibitory concentrations. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona. On May 8, 2025, Accelerate Diagnostics, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Compare 0H8E to Peers and Sector
Metrics to compare | 0H8E | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship0H8EPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −2.7x | −0.5x | |
PEG Ratio | 0.00 | 0.16 | 0.00 | |
Price/Book | 0.0x | 2.5x | 2.6x | |
Price / LTM Sales | 0.1x | 2.4x | 3.0x | |
Upside (Analyst Target) | - | 60.4% | 54.1% | |
Fair Value Upside | Unlock | 4.9% | 8.7% | Unlock |
Earnings
Latest Release
Mar 21, 2025
EPS / Forecast
-0.38 / --
Revenue / Forecast
2.82M / --
People Also Watch
FAQ
What Is the Accelerate Diagnostics Inc (0H8E) Stock Price Today?
The Accelerate Diagnostics Inc stock price today is 0.02
What Stock Exchange Does Accelerate Diagnostics Inc Trade On?
Accelerate Diagnostics Inc is listed and trades on the London Stock Exchange stock exchange.
What Is the Stock Symbol for Accelerate Diagnostics Inc?
The stock symbol for Accelerate Diagnostics Inc is "0H8E."
What Is the Accelerate Diagnostics Inc Market Cap?
As of today, Accelerate Diagnostics Inc market cap is 755.60K.
What Is Accelerate Diagnostics Inc's Earnings Per Share (TTM)?
The Accelerate Diagnostics Inc EPS (TTM) is -2.15.
From a Technical Analysis Perspective, Is 0H8E a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.